Status | Study |
Completed |
Study Name: Topical Brinzolamide Ophthalmic Suspension Versus Placebo in the Treatment of Infantile Nystagmus Syndrome Condition: Infantile Nystagmus Syndrome Date: 2011-01-21 Interventions: Drug: topical brinzolamide 1% in 5mL ophthalmic medication |
Completed |
Study Name: Cross-over Comparison of Gabapentin and Memantine as Treatment for Acquired Nystagmus Condition: Nystagmus Date: 2009-06-25 Interventions: Drug: gabapentin increasing to |
Completed |
Study Name: Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo Condition: HC-BPPV Date: 2008-12-17 Interventions: Procedure: Gufoni maneuver For |
Recruiting |
Study Name: Clinical, Cellular, and Molecular Investigation Into Oculocutaneous Albinism Condition: Albinism Oculocutaneous Albinism Foveal Hypoplasia Date: 2008-12-12 |
Terminated |
Study Name: Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus Condition: Nystagmus, Congenital Nystagmus, A Date: 2008-11-27 Interventions: Drug: Neramexane mesylate open-label treatment of 36 months Neramexane mesylate up to 75 mg per day |
Completed |
Study Name: Effect of Vestibular Rehabilitation - a Randomized Controlled Trial Condition: Dizziness Nausea Nystagmus Date: 2008-06-19 Interventions: Behavioral: Vestibular rehabilitation |
Completed |
Study Name: Efficacy and Safety Study of Neramexane to Treat Congenital and Acquired Nystagmus Condition: Nystagmus, Congenital Idiopathic Nystagmu Date: 2008-04-15 Interventions: Drug: Neramexane mesylate 2 double-blind, cross-over treatment periods of 7 weeks separated by a wash-ou |
Terminated |
Study Name: Visual Impairment, Oscillopsia and Multiple Sclerosis Condition: Multiple Sclerosis Date: 2007-07-06 Interventions: Procedure: visual tests |
Completed |
Study Name: Evaluation and Treatment of Pediatric, Developmental, and Genetic Eye Diseases Condition: Eye Diseases Date: 2004-01-16 |
Completed |
Study Name: Evaluation and Treatment of Pediatric Eye Diseases Condition: Ocular Motility Disorder Date: 2000-10-27 Interventions: Procedure: current standard of care treatments |